[1
]
Michel Bolla, Centre Hospitalier Universitaire de Grenoble, Grenoble; Philippe Maingon,
Georges-Francois-Leclerc Centre, Dijon; Christian Carrie, Leon Bérard Center, Lyon;
Jean-François Bosset, University Hospital of Besancon-Jean Minjoz Hospital, Besancon,
France; Salvador Villa, University Hospital Germans Trias I Pujol, Barcelona, Spain;
Petros Kitsios, Bank of Cyprus Oncology Centre, Nicosia, Cyprus; Philip M.P. Poortmans,
Radboud University Medical Center Nijmegen, Nijmegen; Elzbieta M. van der Steen-Banasik,
Arnhem Radiotherapy Institute, Arnhem; Bradley Pieters, University of Amsterdam, Amsterdam;
Annerie Slot, Radiotherapeutisch Instituut Friesland, Leeuwarden; Alphonsus C.M. van
den Bergh, University of Groningen, Groningen, the Netherlands; Santhanam Sundar,
Nottingham University Hospitals National Health Service Trust-City Hospital, Nottingham;
Amit Bahl, University Hospitals Bristol National Health Service Foundation Trust-Bristol
Haematology and Oncology Centre, Bristol Avon; Christopher Scrase, Ipswich Hospital
National Health Service Trust, Ipswich, United Kingdom; John Armstrong, St Luke's
Hospital, Dublin, Ireland; Fernanda G. Herrera, University Hospital of Lausanne, Lausanne,
Switzerland; Rahamim Ben-Yosef, Rambam Health Care Campus, Haïfa, Israel; Dirk Boehmer,
Charite-Universitaetsmedizin Berlin-Campus Mitte, Berlin, Germany; Laurette Renard,
Cliniques Universitaires Saint Luc; Emad Shash, Corneel Coens, and Laurence Collette,
European Organisation for Research and Treatment of Cancer, Brussels, Belgium; and
Emad Shash, Cairo University, Cairo, Egypt. mbolla@chu-grenoble.fr.
[2
]
Michel Bolla, Centre Hospitalier Universitaire de Grenoble, Grenoble; Philippe Maingon,
Georges-Francois-Leclerc Centre, Dijon; Christian Carrie, Leon Bérard Center, Lyon;
Jean-François Bosset, University Hospital of Besancon-Jean Minjoz Hospital, Besancon,
France; Salvador Villa, University Hospital Germans Trias I Pujol, Barcelona, Spain;
Petros Kitsios, Bank of Cyprus Oncology Centre, Nicosia, Cyprus; Philip M.P. Poortmans,
Radboud University Medical Center Nijmegen, Nijmegen; Elzbieta M. van der Steen-Banasik,
Arnhem Radiotherapy Institute, Arnhem; Bradley Pieters, University of Amsterdam, Amsterdam;
Annerie Slot, Radiotherapeutisch Instituut Friesland, Leeuwarden; Alphonsus C.M. van
den Bergh, University of Groningen, Groningen, the Netherlands; Santhanam Sundar,
Nottingham University Hospitals National Health Service Trust-City Hospital, Nottingham;
Amit Bahl, University Hospitals Bristol National Health Service Foundation Trust-Bristol
Haematology and Oncology Centre, Bristol Avon; Christopher Scrase, Ipswich Hospital
National Health Service Trust, Ipswich, United Kingdom; John Armstrong, St Luke's
Hospital, Dublin, Ireland; Fernanda G. Herrera, University Hospital of Lausanne, Lausanne,
Switzerland; Rahamim Ben-Yosef, Rambam Health Care Campus, Haïfa, Israel; Dirk Boehmer,
Charite-Universitaetsmedizin Berlin-Campus Mitte, Berlin, Germany; Laurette Renard,
Cliniques Universitaires Saint Luc; Emad Shash, Corneel Coens, and Laurence Collette,
European Organisation for Research and Treatment of Cancer, Brussels, Belgium; and
Emad Shash, Cairo University, Cairo, Egypt.